AVENTIS DROPS ALLEGRA ADS AFTER DDMAC ISSUES LETTER

Drug Industry Daily
KEYWORDS Advertising / FDA
A A

Several print and television ads for Aventis Pharmaceuticals’ leading allergy product have been pulled following the FDA’s assertion that the ads made misleading superiority claims over other remedies, the firm announced on Wednesday.

To View This Article:

Login

Subscribe To Drug Industry Daily